骨向的纳米颗粒药物输送系统介导的巨细胞调制,用于增强骨折愈合
Baixue Xiao1,2, Yuxuan Liu3, Indika Chandrasiri1,2
1Department of Biomedical Engineering, University of Rochester, Rochester, NY, 14623, USA.
Small (Weinheim an der Bergstrasse, Germany)
|October 5, 2023
概括
这项研究开发了向的纳米粒子 (NP) 来提供用于骨折愈合的药物. 这些NP通过重编程巨细胞来增强愈合,为骨修复提供了一种新的治疗策略.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 纳米技术 纳米技术
背景情况:
- 开发有效的,最少侵入性的骨特异性药物输送系统 (DDS) 来治疗骨折仍然是一个挑战.
- 目前的纳米粒子 (NP) DDS方法在准和机制理解方面存在局限性.
研究的目的:
- 研究一种提供GSK3β抑制剂 (AR28) 的TRAP结合功能化NP (TBP-NP) 增强骨折愈合的机制.
- 探索巨细胞在TBP-NP介导的骨修复中的作用.
主要方法:
- 开发了通过TRAP向的功能化的聚乙烯-高烯-基无水化) -b-多乙烯) NP.
- 在实验室中与前骨质细胞和巨细胞进行共同培养研究,以评估NP吸收和影响.
- 针对TBP-NP输送的骨折愈合的体内纵向分析,包括基因表达和巨分极分析.
主要成果:
- 提供AR28的TBP-NP加速骨折愈合.
- NP主要被骨折相关的巨细胞吸收,促进M2极化.
- 在体外和体内研究表明,骨质生成增强,并转向抗炎M2巨类型的表型.
结论:
- 针对骨的NP DDS可以利用巨细胞作为治疗点.
- 通过TBP-NP调节M2巨细胞极化是增强骨折愈合的关键机制.
- 这种方法显示了骨折和其他骨相关疾病的治疗潜力.
相关概念视频
Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


